April 11, 2016 Cover
Volume 94, Issue 15
Could low-cost manufacturing techniques finally broaden commercial adoption of the two-dimensional material?
First-time disclosures symposium spotlights the process of developing clinical candidates
$400 million deal adds ACC inhibitors to Gilead’s liver disease pipeline
As the first U.S. plants come on-line, the path forward may lead away from home
Flexible adhesive patch could lead to better electrodes for heart monitors and fitness sensors